genOway Shanghai is a joint venture company founded by genOway and a group of Chinese executives with longstanding experience in life sciences in China.

genOway Shanghai is the exclusive source of genOway catalog models in China, thus giving all Chinese researchers access to the most innovative and reliable preclinical models.
genOway’s catalog models ensure ultimate predictability in preclinical research thanks to their physiological relevance. This is due to their comprehensive and reliable set of validation data, obtained through a close collaboration with top biopharma companies worldwide.
The company already consists of a team of 15 professionals mainly composed of experts in immunology and preclinical science capable of bringing high scientific value to Chinese researchers. In the near future, the headcount will double to increase the scientific expertise and value provided to its clients even further.

genOway Shanghai’s primary goal is to become the #1 partner of excellence for Chinese biopharma and academic research.
The partnership also aims to source and leverage all of the best innovations from China – which has become one of the biggest and most dynamic preclinical research hubs – to make them accessible to all researchers worldwide through genOway’s unique scientific and business network with international pharmaceutical companies, biotech companies and academic leaders..

From model design to experimental results
Featured in 600+ scientific articles
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Generated with biopharma partners and in-house
and guaranteed freedom to operate
Models with certified health status from professional breeders in US and Europe